Next Article in Journal
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Next Article in Special Issue
Impact of CNS Diseases on Drug Delivery to Brain Extracellular and Intracellular Target Sites in Human: A “WHAT-IF” Simulation Study
Previous Article in Journal
Control Strategy for Process Development of High-Shear Wet Granulation and Roller Compaction to Prepare a Combination Drug Using Integrated Quality by Design
Previous Article in Special Issue
SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier
Article

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

1
Institute of Enzymology, ELKH Research Centre for Natural Sciences, Magyar Tudósok krt. 2, 1117 Budapest, Hungary
2
SOLVO Biotechnology, Irinyi József Street 4-20, 1117 Budapest, Hungary
3
Doctoral School of Molecular Medicine, Semmelweis University, Tűzoltó u. 37-47, 1094 Budapest, Hungary
4
Department of Biophysics and Radiation Biology, Semmelweis University, Tűzoltó u. 37-47, 1094 Budapest, Hungary
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceutics 2021, 13(1), 81; https://doi.org/10.3390/pharmaceutics13010081
Received: 21 November 2020 / Revised: 28 December 2020 / Accepted: 31 December 2020 / Published: 9 January 2021
(This article belongs to the Special Issue Drug Delivery across Physiological Barriers)
During the COVID-19 pandemic, several repurposed drugs have been proposed to alleviate the major health effects of the disease. These drugs are often applied with analgesics or non-steroid anti-inflammatory compounds, and co-morbid patients may also be treated with anticancer, cholesterol-lowering, or antidiabetic agents. Since drug ADME-tox properties may be significantly affected by multispecific transporters, in this study, we examined the interactions of the repurposed drugs with the key human multidrug transporters present in the major tissue barriers and strongly affecting the pharmacokinetics. Our in vitro studies, using a variety of model systems, explored the interactions of the antimalarial agents chloroquine and hydroxychloroquine; the antihelmintic ivermectin; and the proposed antiviral compounds ritonavir, lopinavir, favipiravir, and remdesivir with the ABCB1/Pgp, ABCG2/BCRP, and ABCC1/MRP1 exporters, as well as the organic anion-transporting polypeptide (OATP)2B1 and OATP1A2 uptake transporters. The results presented here show numerous pharmacologically relevant transporter interactions and may provide a warning on the potential toxicities of these repurposed drugs, especially in drug combinations at the clinic. View Full-Text
Keywords: anti-COVID-19 agents; repurposed drugs; APP-Binding Cassette (ABC) transporters; OATP transporters; in vitro functional studies anti-COVID-19 agents; repurposed drugs; APP-Binding Cassette (ABC) transporters; OATP transporters; in vitro functional studies
Show Figures

Figure 1

MDPI and ACS Style

Telbisz, Á.; Ambrus, C.; Mózner, O.; Szabó, E.; Várady, G.; Bakos, É.; Sarkadi, B.; Özvegy-Laczka, C. Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics 2021, 13, 81. https://doi.org/10.3390/pharmaceutics13010081

AMA Style

Telbisz Á, Ambrus C, Mózner O, Szabó E, Várady G, Bakos É, Sarkadi B, Özvegy-Laczka C. Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics. 2021; 13(1):81. https://doi.org/10.3390/pharmaceutics13010081

Chicago/Turabian Style

Telbisz, Ágnes, Csilla Ambrus, Orsolya Mózner, Edit Szabó, György Várady, Éva Bakos, Balázs Sarkadi, and Csilla Özvegy-Laczka. 2021. "Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters" Pharmaceutics 13, no. 1: 81. https://doi.org/10.3390/pharmaceutics13010081

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop